Quantitative systems-level determinants of human genes targeted by successful drugs
Authors:
- 14 December 2007
- journal article
- research article
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 18 (2) , 206-213
Abstract
What makes a successful drug target? A target molecule with an appropriate (druggable) tertiary structure is a necessary but not the sufficient condition for success. Here we analyzed specific properties of human genes and proteins targeted by 919 FDA-approved drugs and identified several quantitative measures that distinguish them from other genes and proteins at a highly significant level. Compared to an average gene and its encoded protein(s), successful drug targets are more highly connected (but far from being the most highly connected), have higher betweenness values, lower entropies of tissue expression, and lower ratios of nonsynonymous to synonymous single-nucleotide polymorphisms. Furthermore, we have identified human tissues that are significantly over- or undertargeted relative to the full spectrum of genes that are active in each tissue. Our study provides quantitative guidelines that could aid in the computational screening of new drug targets in human cells.Keywords
This publication has 27 references indexed in Scilit:
- Case histories, magic bullets and the state of drug discoveryNature Reviews Drug Discovery, 2006
- Estimating The Cost Of New Drug Development: Is It Really $802 Million?Health Affairs, 2006
- Towards a proteome-scale map of the human protein–protein interaction networkNature, 2005
- The Target Discovery ProcessChemBioChem, 2005
- GeneWays: a system for extracting, analyzing, visualizing, and integrating molecular pathway dataJournal of Biomedical Informatics, 2004
- Human protein reference database as a discovery resource for proteomicsNucleic Acids Research, 2004
- Drug receptor/effector polymorphisms and pharmacogeneticsPharmacogenetics, 2003
- Exact scaling properties of a hierarchical network modelPhysical Review E, 2003
- Growing scale-free networks with tunable clusteringPhysical Review E, 2002
- Human disease genesNature, 2001